The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
Open accessAbstract
With a political debate about the potential risks and benefits of cannabis use as a backdrop, the wave of legalization and liberalization initiatives continues to spread. Four states (Colorado, Washington, Oregon, and Alaska) and the District of Columbia have passed laws that legalized cannabis for recreational use by adults, and 23 others plus the District of Columbia now regulate cannabis use for medical purposes. These policy changes could trigger a broad range of unintended consequences, with profound and lasting implications for the health and social systems in our country. Cannabis use is emerging as one among many interacting factors that can affect brain development and mental function. To inform the political discourse with scientific evidence, the literature was reviewed to identify what is known and not known about the effects of cannabis use on human behavior, including cognition, motivation, and psychosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It manifests as a reduce motivation to engage in everyday activities such as a diminished desire to study or work, engage in social or recreational activities people who use cannabis frequently [32].”
From Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits (2025) · cites this paper as [32]
In the citing paper
“Specifically, chronic cannabis users have smaller volumes of the orbitofrontal cortex, a brain region implicated in motivation, and the hippocampus, a brain area implicated in stress, learning and memory [32].”
From Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits (2025) · cites this paper as [32]
In the citing paper
“Cannabis users and people intoxicated with THC had altered function in the same regions and in brain striatal areas implicated in reward processing.”
From Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits (2025) · cites this paper as [32]
In the citing paper
“Specifically, chronic cannabis users have smaller volumes of the orbitofrontal cortex, a brain region implicated in motivation, and the hippocampus, a brain area implicated in stress, learning and memory [32].”
From Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits (2025) · cites this paper as [32]
Citations
Cites
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
Berridge, K. C., & Robinson, T. E. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00019-8 · Cited by 4,127
Endocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno‐Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,595
Persistent cannabis users show neuropsychological decline from childhood to midlife
Meier, M. H., Caspi, A., Ambler, A., Harrington, H., Houts, R., Keefe, R. S. E., McDonald, K., Ward, A., Poulton, R., & Moffitt, T. E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206820109 · Cited by 1,523
Self-citationCaspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.026 · Cited by 1,409
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.
Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002) · BMJ · doi:10.1136/bmj.325.7374.1212 · Cited by 1,399
Cannabis and schizophrenia. A longitudinal study of Swedish conscripts
Andréasson, S., Engström, A., Allebeck, P., & Rydberg, U. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92620-1 · Cited by 1,166
Apathy: a neuropsychiatric syndrome
Marin, R. S. (1991) · Journal of Neuropsychiatry · doi:10.1176/jnp.3.3.243 · Cited by 1,088
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024
Cannabis use and psychosis: A longitudinal population-based study
van Os, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf043 · Cited by 928
Cited by
Sorted by citations
Items 401–500 of 865
Cannabinoïdes et thérapeutique
Fabresse, N., Becam, J., Carrara, L., Descoeur, J., Mario, M. D., Drevin, G., Duval, T., Hannas, N., Lanot, T., Marillier, M., et al. (2019) · Annales de Toxicologie Analytique · doi:10.1016/j.toxac.2019.06.002 · Cited by 10
Risk Markers for Women’s Physical Intimate Partner Violence Victimization in Iran: A Meta-Analysis
Nikparvar, F., Spencer, C. M., & Stith, S. M. (2020) · Violence Against Women · doi:10.1177/1077801220965744 · Cited by 13
Pacheco‐Colón, I., Hawes, S. W., Duperrouzel, J. C., & González, R. (2021) · Journal of the International Neuropsychological Society · doi:10.1017/s135561772000096x · Cited by 10
Yuferov, V. P., Butelman, E. R., & Kreek, M. J. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s159954 · Cited by 10
Cannabis use, legalization and youth health
Fischer, B., & Rehm, J. T. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.733215 · Cited by 10
Köck, P., Lang, E., Trulley, V.-N., Dechent, F., Mercer‐Chalmers‐Bender, K., Frei, P., Huber, C. G., & Borgwardt, S. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.736822 · Cited by 9
Puri, S., Ong, C. B., Chiu, Y.-F., Lebowitz, J., Sideris, A., Valle, A. G. D., & Chalmers, B. P. (2023) · HSS Journal® The Musculoskeletal Journal of Hospital for Special Surgery · doi:10.1177/15563316221151158 · Cited by 9
Ney, L. J., Akóṣílè, W., Davey, C. G., Pitcher, L., Felmingham, K. L., Mayo, L. M., Hill, M. N., & Strodl, E. S. (2023) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2276309 · Cited by 9
Bartolomeo, M. D., Čerňanová, A., Petrušová, V., Martino, S. D., Hodosy, J., Drago, F., Micale, V., & D’Addario, C. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107343 · Cited by 9
Dendup, T., Putra, I. G. N. E., Dorji, T., Tobgay, T., Dorji, G., Phuntsho, S., & Tshering, P. (2020) · Children and Youth Services Review · doi:10.1016/j.childyouth.2020.105520 · Cited by 9
Curry, J. F., Kaminer, Y., Goldston, D. B., Chan, G., Wells, K. C., Burke, R. H., Inscoe, A. B., Meyer, A. E., & Cheek, S. M. (2021) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2021.07.807 · Cited by 9
O’Hara, S. E., Paschall, M. J., & Grube, J. W. (2023) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.22-00277 · Cited by 9
Fink, D. S., Malte, C. A., Cerdá, M., Mannes, Z. L., Livne, O., Martins, S. S., Keyhani, S., Olfson, M., McDowell, Y. E., Gradus, J. L., et al. (2023) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001197 · Cited by 9
Slawek, D. E., Althouse, A. D., Feldman, R., Arnsten, J. H., Bulls, H. W., Liebschutz, J. M., Nugent, S. M., Orris, S. R., Rohac, R., Starrels, J. L., et al. (2023) · BMC Family Practice · doi:10.1186/s12875-023-02095-5 · Cited by 9
The Development of Cannabinoids as Therapeutic Agents in the United States
Murray, C. H., Gannon, B. M., Winsauer, P. J., Cooper, Z. D., & Delatte, M. S. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001121 · Cited by 10
The impact of current cannabis use on general cognitive function in people with psychotic illness
Waterreus, A. J., Badcock, J. C., Prinzio, P. D., Martin-Iverson, M. T., & Morgan, V. A. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.03.038 · Cited by 9
Cannabis for medical use: a scientific review.
Dillon, L. (2017) · Cited by 9
Age of onset of cannabis use and decision making under uncertainty
Bailén, J. R. A., Alcañiz, M. D. P. S., Merchán-Clavellino, A., & Paíno-Quesada, S. (2018) · PeerJ · doi:10.7717/peerj.5201 · Cited by 13
Vancampfort, D., Firth, J., Smith, L., Stubbs, B., Rosenbaum, S., Damme, T. V., Christiaansen, L., Ashdown‐Franks, G., & Koyanagi, A. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2019.106104 · Cited by 9
Coronado, C., Wade, N. E., Aguinaldo, L. D., Mejia, M. H., & Jacobus, J. (2020) · Journal of Pediatric Neuropsychology · doi:10.1007/s40817-020-00076-5 · Cited by 14
Rafei, P., Rezapour, T., Batouli, S. A. H., Verdejo‐García, A., Lorenzetti, V., & Hatami, J. (2021) · Psychopharmacology · doi:10.1007/s00213-021-06002-7 · Cited by 9
Cannabis use among youth in Canada: a scoping review protocol
Kourgiantakis, T., Edwards, T., Lee, E., Logan, J. R., Vicknarajah, R., Craig, S. L., Simon-Tucker, M., & Williams, C. C. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-061997 · Cited by 9
Quantitative Criteria to Screen for Cannabis Use Disorder
Casajuana, C., López‐Pelayo, H., Miquel, L., Balcells‐Oliveró, M., Colom, J., & Gual, A. (2018) · European Addiction Research · doi:10.1159/000488346 · Cited by 9
Enhancing Fear Extinction: Pharmacological Approaches
Ponomareva, O. Y., Fenster, R. J., & Ressler, K. J. (2023) · Current topics in behavioral neurosciences · doi:10.1007/7854_2023_443 · Cited by 7
Gex, K. S., Leone, R. M., Aungst, J., Branson, K., Gray, K. M., & Tomko, R. L. (2024) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2024.209335 · Cited by 8
Rethinking the role of trazodone in the different depressive dimensions
Berardelli, I., Amerio, A., Bartoli, F., Cuomo, A., Deste, G., Orsolini, L., Sampogna, G., & Pompili, M. (2024) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2024.2363843 · Cited by 9
Rehm, J. T., Crépault, J., & Fischer, B. (2016) · International Journal of Health Policy and Management · doi:10.15171/ijhpm.2016.114 · Cited by 8
High-CBD Cannabis Vapor Attenuates Opioid Reward and Partially Modulates Nociception in Female Rats
Rivera-Garcia, M. T., Rose, R. M., & Wilson‐Poe, A. R. (2022) · Addiction Neuroscience · doi:10.1016/j.addicn.2022.100050 · Cited by 11
Hazardous or not? Cannabis use and early labor market experiences of young men
Williams, J., & OURS, J. C. V. (2020) · Health Economics · doi:10.1002/hec.4125 · Cited by 8
Delta-9-tetrahydrocannabinol reduces willingness to exert effort in women
Wardle, M. C., Pabon, E., Webber, H. E., & de Wit, H. (2022) · Psychopharmacology · doi:10.1007/s00213-021-06032-1 · Cited by 9
Croker, J. A., Werts, M., Couch, E. T., & Chaffee, B. W. (2023) · Addictive Behaviors · doi:10.1016/j.addbeh.2023.107620 · Cited by 8
Davies, B., De Marco, G., Levy, N. L., & Savulescu, J. (2024) · doi:10.1093/oso/9780192872234.001.0001 · Cited by 7
Passing on Pot: High School Seniors’ Reasons for Not Using Marijuana as Predictors of Future Use
Martz, M. E., Schulenberg, J. E., & Patrick, M. E. (2018) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2018.79.761 · Cited by 8
Marijuana use and candidacy for heart transplantation
DeFilippis, E. M., & Givertz, M. M. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.03.011 · Cited by 8
Pilatti, A., Kuntsche, E. N., Acosta, B., Díaz, J. B., Caneto, F., & Pautassi, R. M. (2021) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-021-00689-7 · Cited by 8
Effects of Cannabis Use on Human Behavior—Reply
Volkow, N. D. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.1332 · Cited by 8
Self-citationTeen Reports of Cannabis for Medical Reasons—What Does That Mean?
Budney, A. J. (2020) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2020.09.044 · Cited by 8
DeLisi, L. E. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.05.002 · Cited by 8
Self-citationLoreto, B. B. L., Sordi, A. O., de Castro, M. N., Ornell, F. R., Guarnieri, E. P., Roza, T. H., Schuch, J. B., Cima, M. D. S., Pechansky, F., Grevet, E. H., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1298002 · Cited by 9
Adolescent THC impacts on mPFC dopamine-mediated cognitive processes in male and female rats
Martinez, M. X., Vera, V. A., Ruiz, C. M., Floresco, S., & Mahler, S. V. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06676-9 · Cited by 7
Epidemiology of Cannabis Use Among Middle-Aged and Older Adults in the U.S.
Livne, O., Stohl, M., Gilman, J. M., Goldberg, T. E., Wall, M. M., & Hasin, D. S. (2025) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2025.108149 · Cited by 10
Livne, O., Potter, K. W., Schuster, R. M., & Gilman, J. M. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0310 · Cited by 7
Cantillano, V., Villar, P. D., Contreras, L., Martínez, D. M., Zuzulich, M. S., Ramírez, C., Pons, C., & Bashford, J. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.10.032 · Cited by 7
Gir sterkere cannabis flere helseproblemer?
Vindenes, V., Bramness, J. G., Bretteville‐Jensen, A. L., Mørland, J. G., & Bachs, L. C. (2016) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.15.1297 · Cited by 7
Cougle, J. R., McDermott, K. A., Hakes, J. K., & Joyner, K. J. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.029 · Cited by 7
Feingold, D., Brill, S., Goor‐Aryeh, I., Delayahu, Y., & Lev‐Ran, S. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110130 · Cited by 7
Cannabis and Complex Posttraumatic Stress Disorder
Dagan, Y., & Yager, J. (2020) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001172 · Cited by 7
Mahdi, O., Baharuldin, M. T. H., Nor, N. H. M., Chiroma, S. M., Jagadeesan, S., & Moklas, M. A. M. (2021) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524921666210127110028 · Cited by 6
Motivation to use cannabis among young adults at a University in Botswana
Kgatitswe, B. M., & Amone‐P’Olak, K. (2017) · African Journal of Drug and Alcohol Studies · Cited by 7
Knox, J., Hwang, G., Carrico, A. W., Duncan, D. T., Watson, R. J., & Eaton, L. A. (2022) · AIDS and Behavior · doi:10.1007/s10461-022-03598-5 · Cited by 6
Livne, O., Budney, A. J., Borodovsky, J. T., Shmulewitz, D., Walsh, C. A., Struble, C. A., Habib, M. I., Aharonovich, E., & Hasin, D. S. (2024) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2024.2309340 · Cited by 7
Verrico, C. D., Mathai, D. S., Gu, H., Sampson, A. R., & Lewis, D. A. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119882857 · Cited by 8
Heterogeneous peer effects on marijuana use: Evidence from a natural experiment
Li, Y., & Guo, G. (2020) · Social Science & Medicine · doi:10.1016/j.socscimed.2020.112907 · Cited by 8
Cannabinoids and Brain Damage: A Systematic Review on a Frequently Overlooked Issue
Scopetti, M., Morena, D., Manetti, F., Santurro, A., Fazio, N. D., D’Errico, S., Padovano, M., Frati, P., & Fineschi, V. (2022) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023666220614145535 · Cited by 7
Cannabis, Decision‐Making, and Online Assistance Seeking
Evans, M., Ogeil, R. P., & Phillips, J. G. (2019) · American Journal on Addictions · doi:10.1111/ajad.12960 · Cited by 7
Differentiating people who use cannabis heavily through latent class analysis
Roldán, A. Á., García‐Muñoz, T., Gamella, J. F., Toro, I. P., & Duaso, M. J. (2023) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-023-00540-3 · Cited by 6
Art therapy’s engagement of brain networks for enduring recovery from addiction
Quinn, P. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1458063 · Cited by 7
Cannabis Hyperemesis Syndrome in Youth: Clinical Insights and Public Health Implications
Seabrook, J. A., Seabrook, M., & Gilliland, J. (2025) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph22040633 · Cited by 6
Product features for promoting top-selling cannabis vape products in an online retail environment
Chen-Sankey, J. C., Capria, K. L., Meng, S., Mazzeo, R., Vijayakumar, N., Padon, A. A., Wagoner, K. G., Moran, M. B., Rossheim, M. E., Berg, C. J., et al. (2025) · Addiction Research & Theory · doi:10.1080/16066359.2025.2519601 · Cited by 6
Mohebbian, M., Najafi, S., Choi, Y. N., Schütz, C. G., Kassam, R., Kazanjian, A., & Puyat, J. H. (2025) · PLOS mental health. · doi:10.1371/journal.pmen.0000358 · Cited by 6
Impacts de la légalisation du cannabis récréatif sur la santé mentale : une recension des écrits
Gouron, D., Vignault, C., Quintin, J., Semaan, W., & Asli, K. D. (2020) · Santé mentale au Québec · doi:10.7202/1070247ar · Cited by 6
Neuropsychological and Behavioral Aspects of Drug Use and Abuse: Theory, Research, and Intervention
Lopes, F. M., Boos, F. Z., Zanini, A. M., & Czermainski, F. R. (2021) · Springer eBooks · doi:10.1007/978-3-030-62855-0_11 · Cited by 6
Nieto, S. J., Venegas, A., Burnette, E. M., MacKillop, J., & Ray, L. A. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05993-7 · Cited by 6
Brunette, M. F., Roth, R. M., Trask, C. L., Khokhar, J. Y., Ford, J., Park, S. H., Hickey, S. M., Zeffiro, T. A., & Xie, H. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae097 · Cited by 6
Procter, N. G., Hamer, H. P., McGarry, D. E., Wilson, R. L., & Froggatt, T. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316718278 · Cited by 6
Cannabis Use and Nonfatal Opioid Overdose among Patients Enrolled in Methadone Maintenance Treatment
Bryson, W. C., Morasco, B. J., Cotton, B. P., & Thielke, S. M. (2021) · Substance Use & Misuse · doi:10.1080/10826084.2021.1892137 · Cited by 6
Nassif, R. N. (2021) · Cureus · doi:10.7759/cureus.15615 · Cited by 6
Rammouz, I., & Boujraf, S. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0051 · Cited by 6
Medical marijuana for inflammatory bowel disease: the highs and lows
Wynne, J., & Kozuch, P. L. (2021) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2021.1998604 · Cited by 6
Choi, N. G., DiNitto, D. M., Marti, C. N., & Choi, B. Y. (2022) · Journal of Applied Gerontology · doi:10.1177/07334648211069997 · Cited by 6
Baranauskas, M., Kupčiūnaitė, I., & Stukas, R. (2022) · Sustainability · doi:10.3390/su142013063 · Cited by 8
Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder
Phan, A. N., & Terry, G. E. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1144276 · Cited by 6
Framing substance use as “recreational” is neither accurate nor helpful for prevention purposes
Sanchez, Z. M., Folgar, M. I., Matias, J. P., Pimentel, M. P., & Burkhart, G. (2023) · Journal of Prevention · doi:10.1007/s10935-023-00745-z · Cited by 8
Predictors of Cannabis Use Among Canadian University Students
Llewelyn-Williams, J., & Mykota, D. B. (2023) · Cannabis · doi:10.26828/cannabis/2023/000160 · Cited by 6
Cohen, J. P., Petitjean, H., Blasco, M. B., & Mizrahi, R. (2024) · Acta Neuropsychiatrica · doi:10.1017/neu.2023.60 · Cited by 6
López‐Pelayo, H., Campeny, E., Oliveras, C., Rehm, J. T., Manthey, J., Gual, A., & Balcells‐Oliveró, M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.643556 · Cited by 7
Penile self-amputation due to cannabis-induced psychosis: a case report
Jengsuebsant, N., Benjachaya, S., Vuthiwong, J., & Tangsuwanaruk, T. (2022) · Journal of Medical Case Reports · doi:10.1186/s13256-022-03267-0 · Cited by 6
The Current Evidence for Marijuana as Medical Treatment
Buck, J. S., Bloomer, A. K., Wally, M. K., Seymour, R. B., & Hsu, J. R. (2020) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.20.00269 · Cited by 6
Troup, L. J., Andrzejewski, J. A., & Torrence, R. D. (2019) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000265 · Cited by 6
Hatz, L. E., Courtney, K. E., Wallace, A. L., Wade, N. E., Baca, R. E., Doran, N., & Jacobus, J. (2025) · Frontiers in Adolescent Medicine · doi:10.3389/fradm.2025.1486782 · Cited by 5
Evans‐Polce, R. J., Mongilio, J. M., McCabe, S. E., & Veliz, P. T. (2025) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2025.108033 · Cited by 5
Chen-Sankey, J. C., LoParco, C. R., Capria, K. L., Meng, S., Mazzeo, R., Vijayakumar, N., Kong, A. Y., Tillett, K. K., Berg, C. J., & Rossheim, M. E. (2025) · Substance Use & Misuse · doi:10.1080/10826084.2025.2555499 · Cited by 5
Tkalić, R. G., Vuolo, M., & Wertag, A. (2025) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2025.100387 · Cited by 7
Trends in cannabis use disorder and treatment by race and ethnicity, 2002–2019
Roura, M. T., Vora, A., Eschliman, E. L., & Mauro, P. M. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1689719 · Cited by 7
Cannabis Use Among US Adolescents
Sultan, R. S., Zhang, A. W., Becker, T. D., Sethaputra, P., Simon, K. M., Huang, Y., LEVIN, F. R., Levy, S., & Olfson, M. (2025) · PEDIATRICS · doi:10.1542/peds.2024-070509 · Cited by 5
Prashad, S., Paek, A. Y., & Fournier, L. R. (2026) · PLoS ONE · doi:10.1371/journal.pone.0338082 · Cited by 5
Akerele, E. (2022) · Springer eBooks · doi:10.1007/978-3-030-84834-7_19 · Cited by 5
Commercial Cannabidiol for Community-Based Young Adolescents: Predicting Medicinal Use
Wade, N. E., Nguyen‐Louie, T. T., Wallace, A. L., Sullivan, R. M., & Tapert, S. F. (2024) · Cannabis and Cannabinoid Research · doi:10.1089/can.2024.0015 · Cited by 5
David, A., Stolar, O. E., Berkovitch, M., Kohn, E., Hazan, A., Waissengreen, D., & Gal, E. (2024) · Cannabis and Cannabinoid Research · doi:10.1089/can.2024.0001 · Cited by 5
Cannabidiol Use and Perceptions of Effectiveness in Women With Chronic Pelvic Pain
Till, S. R., Whitmore, G. T., As‐Sanie, S., Matallana, L. K., & Boehnke, K. F. (2025) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2025.102839 · Cited by 5
Murri, M. B., Catania, S., Centra, S., Folesani, F., Muscettola, A., Zerbinati, L., Toffanin, T., Ferrara, M., Ossola, P., Rossi, R., et al. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106269 · Cited by 6
Liao, W., Chang, C., & Hsiao, Y. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14856 · Cited by 6
Ullrich, H. S., Torbati, A., Fan, W., Arbona, C., Cano, M. Á., Essa, S., Harvey, L., Vaughan, E. L., & de Dios, M. A. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108561 · Cited by 5
The effect of tetrahydrocannabinol:cannabidiol oromucosal spray on cognition: a systematic review
Motaghi, E., Ghasemi-Pirbaluti, M., Rashidi, M., Alasvand, M., Ciano, P. D., & Bozorgi, H. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03454-y · Cited by 5
Lower-risk substance use guidelines accessible by youth
Moebes, Z. R., Card, K. G., Koenig, B., & Benoit, C. (2023) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-023-00516-3 · Cited by 5
Effect of Preoperative Marijuana on Patient Outcomes and Opioid Use after Lumbar Decompression
Trenchfield, D. R., Lee, Y. A., Brush, P. L., McCurdy, M. T., Lambrechts, M. J., Narayanan, R., Christianson, A., Deez, A., Wiafe, B. M., Kaye, I. D., et al. (2023) · Global Spine Journal · doi:10.1177/21925682231203650 · Cited by 5
Regalado, D., Connolly, M. E., Krutsch, K., Stark, A., Kendall-Tackett, K. A., & Garner, C. D. (2023) · Women s Health · doi:10.1177/17455057231199391 · Cited by 5
Year-Long Cannabis Use for Medical Symptoms and Brain Activation During Cognitive Processes
Burdinski, D., Kodibagkar, A., Potter, K. W., Schuster, R. M., Evins, A. E., Ghosh, S., & Gilman, J. M. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.34354 · Cited by 5
Self-citationMarijuana use and service utilization among adolescents 7 years post substance use treatment
Campbell, C. I., Sterling, S., Chi, F. W., & Kline‐Simon, A. H. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.08.012 · Cited by 5
Hoffman, K. A., Terashima, J. P., McCarty, D. W., & Muench, J. (2017) · World Medical & Health Policy · doi:10.1002/wmh3.237 · Cited by 5
Metadata
- Authors
- Volkow, N. D., Swanson, J. M., Evins, A. E., DeLisi, L. E., Meier, M. H., Gonzalez, R., Bloomfield, M. A. P., Curran, H. V., & Baler, R.
- Affiliations
- National Institutes of Health (US)
- University of California, Irvine (US)
- Harvard University (US)
- Arizona State University (US)
- Center for Children and Families, Department of Psychology, Florida International University, Miami
- Hammersmith Hospital (GB)
- University College London (GB)
- National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland
- ORCID
- Venue
- JAMA Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2016-03-01
- Volume
- 73
- Issue
- 3
- Pages
- 292
- ISSN
- 2168-622X (ISSN-L)
- OpenAlex
- W2264173627
- Cited by
- 867
- References
- 77
- Citations by year
- 2026: 46 · 2025: 85 · 2024: 64 · 2023: 85 · 2022: 81 · 2021: 87 · 2020: 105 · 2019: 102 · 2018: 97 · 2017: 74 · 2016: 40
- FWCI
- 84.45
- Type
- journal article
- Language
- en
- Open access
- green
- discovery.ucl.ac.uk
- Locations
- JAMA Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Bank (Australian Catholic University) (submittedVersion)
- Funders
- FORUM Pharmaceuticals
- National Institute for Health and Care Research (CL-2015-18-005, ACF-2014-18-010)
- British Medical Association
- National Institutes of Health
- Medical Research Council (MR/K015524/1)
- National Institute on Drug Abuse (R01DA021576, R01DA021245, R01DA030992)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Keywords
- cannabis use, recreational cannabis legalization, medical cannabis, cognition, motivation, psychosis, brain development, mental health, cannabis policy
- MeSH terms
- Adult, Behavior, Cannabis, Marijuana Abuse, Cognition, Humans, Legislation, Drug, Motivation, Psychoses, Substance-Induced, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review